MELD-Na Score

Model for End-Stage Liver Disease with Sodium.

Medical Disclaimer

This tool is for educational and screening purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Cirrhosis Prognosis

Bilirubin (mg/dL)

INR

Creatinine (mg/dL)

Sodium (mEq/L)

MELD-Na Score

Used for liver transplant prioritization.

Higher scores correlate with increased 3-month mortality risk.

Found this tool helpful? Share it with your friends!

About MELD-Na Score

The MELD-Na Score is a crucial prognostic model designed to assess the severity of end-stage liver disease. It refines the original MELD score by incorporating serum sodium levels, which accounts for the significant impact of hyponatremia on patient outcomes and mortality risk. This tool is invaluable for clinicians, including transplant surgeons, hepatologists, and intensivists, who manage patients with chronic liver failure. Its primary value lies in providing a more accurate prediction of short-term survival and serving as a critical instrument for prioritizing patients on the liver transplant waiting list, ensuring evidence-based and equitable organ allocation.

Medical Disclaimer

Cirrhosis Prognosis

Bilirubin (mg/dL)

INR

Creatinine (mg/dL)

Sodium (mEq/L)